Thus, K17 expression correlates with major differences in the immune microenvironment, most notably through profound exclusion of CD8+ T cells that is independent of clinicopathologic features or tumor intrinsic variables, treatment history, tumor grade, pathological stage, lymph node status, histologic variant, and tumor mutational status. This evidence concerns the gene KRT17 and neoplasm.